Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Derek Rose

UNCOVERED: Asx soon to get its first erectile dysfunction company | History Defined

LTR Pharma is preparing to launch its SPONTAN nasal spray which treats erectile dysfunction. (HANDOUT/H^CK DIGITAL)

This is one company that probably won't get a limp reception from the market.

Brisbane-based LTR Pharma on Friday opened its $7 million initial public offering to fund its planned launch of a fast-acting treatment for erectile dysfunction. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.